Bison Ventures

Bison Ventures, established in 2021 and based in Seattle, Washington, is a venture capital firm that invests in early-stage technology companies. It focuses on frontier technologies that aim to improve human health and the environment. The firm collaborates with entrepreneurs who leverage innovative research and technology in their ventures. Bison Ventures is a Registered Investment Adviser.

Tom Biegala

Founding Partner

8 past transactions

Frontera Health

Seed Round in 2025
Frontera Health is changing autism care in underprivileged regions with AI-powered tools that assist physicians in evaluating and treating children with autism and related diseases.

Bonsai Robotics

Series A in 2025
Bonsai Robotics, headquartered in San Jose, California, specializes in developing vision-based automation solutions for off-road vehicles, with a particular focus on agricultural machinery. The company's technology enables robotic operation of multiple vehicles through advanced computer vision systems. This allows farmers to enhance productivity, performance, efficiency, and safety while reducing labor dependency. Additionally, Bonsai Robotics offers analytics and telematics services to help growers optimize their operations.

Cadstrom

Seed Round in 2024
Cadstrom is an automated intelligence platform focused on electronic hardware design verification. The company develops electronic design automation tools specifically aimed at designing and validating printed circuit boards. By leveraging artificial intelligence, Cadstrom's tools provide real-time collaboration features such as rule checking, image rendering, and project management. These capabilities enable electronics engineers and designers to enhance their engineering processes, streamline workflows, and reduce the necessity for project revisions.

Passkey

Seed Round in 2024
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs). It is designed to address complex diseases by targeting rare combinations of proteins that work together.

Collaborative Robotics

Series B in 2024
Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction. A future in which robots are trustworthy extensions of the environment. They operate, adapt, and react in response.

Vivodyne

Seed Round in 2023
Vivodyne is a biotechnology company that specializes in developing an advanced automated robotic system aimed at discovering innovative drugs and cellular therapies. The company has created a microfluidic bioengineering platform that focuses on single-cell 4D phenomics, allowing for a detailed exploration of biological complexities. Its technology enables the cultivation of highly realistic human tissue models for drug discovery, incorporating an integrated confocal microscope. This platform not only accelerates the drug development process but also allows researchers to formulate tunable mixtures of compounds and cell therapies. Through its unique approach, Vivodyne seeks to advance the understanding of human health and facilitate the creation of effective treatments for various diseases.

Allonnia

Series A in 2023
Allonnia LLC is a biotechnology company based in Boston, Massachusetts, founded in 2019, that specializes in waste remediation services. The company focuses on developing enzymes, proteins, and microbes that effectively degrade or metabolize environmental contaminants, facilitating the recovery and upcycling of valuable materials from waste. Allonnia aims to provide innovative solutions to pressing environmental challenges, including safer water and cleaner mining, while promoting sustainability. Their unique approach integrates biology with advanced technology to create systems that transform waste into useful resources. Allonnia's commitment to environmental stewardship and innovation has garnered industry recognition, positioning it as a leader in the field of biotechnology and waste management.

Vivodyne

Vivodyne is a biotechnology company that specializes in developing an advanced automated robotic system aimed at discovering innovative drugs and cellular therapies. The company has created a microfluidic bioengineering platform that focuses on single-cell 4D phenomics, allowing for a detailed exploration of biological complexities. Its technology enables the cultivation of highly realistic human tissue models for drug discovery, incorporating an integrated confocal microscope. This platform not only accelerates the drug development process but also allows researchers to formulate tunable mixtures of compounds and cell therapies. Through its unique approach, Vivodyne seeks to advance the understanding of human health and facilitate the creation of effective treatments for various diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.